CgA levels are elevated in AD brain and cerebrospinal fluid (CSF) 8–10, and proteolytic processing of CgA generates a class of bioactive peptides with diverse effects on inflammation, metabolism, and synaptic function. This evidence concerns the gene CGA and Alzheimer disease.